Shenzhen Salubris Pharmaceuticals Co Ltd (002294) — Cash Flow Reinvestment Rate
Shenzhen Salubris Pharmaceuticals Co Ltd (002294) has a Cash Flow Reinvestment Rate of 0.73x as of September 2025, reinvesting CN¥292.24 Million (capex CN¥292.24 Million ) from operating cash flow of CN¥400.70 Million. Explore reinvestment intensity of Shenzhen Salubris Pharmaceuticals Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shenzhen Salubris Pharmaceuticals Co Ltd Cash Flow Reinvestment Rate (2006–2024)
Historical reinvestment intensity for Shenzhen Salubris Pharmaceuticals Co Ltd across 19 annual periods. Also explore Shenzhen Salubris Pharmaceuticals Co Ltd asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Shenzhen Salubris Pharmaceuticals Co Ltd (2006–2024)
Year-by-year capital reinvestment analysis for Shenzhen Salubris Pharmaceuticals Co Ltd. For live market cap and broader valuation context, see market cap of Shenzhen Salubris Pharmaceuticals Co Ltd.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.29x | CN¥1.53 Billion | CN¥1.19 Billion | CN¥624.81 Million | ▼ -45.2% |
| 2023 | 2.35x | CN¥2.04 Billion | CN¥869.79 Million | CN¥671.00 Million | ▲ +77.9% |
| 2022 | 1.32x | CN¥1.28 Billion | CN¥970.80 Million | CN¥598.96 Million | ▲ +171.4% |
| 2021 | 0.49x | CN¥576.03 Million | CN¥1.18 Billion | CN¥482.50 Million | ▼ -23.0% |
| 2020 | 0.63x | CN¥867.50 Million | CN¥1.37 Billion | CN¥642.47 Million | ▲ +39.8% |
| 2019 | 0.45x | CN¥680.11 Million | CN¥1.51 Billion | CN¥457.19 Million | ▼ -19.3% |
| 2018 | 0.56x | CN¥749.80 Million | CN¥1.34 Billion | CN¥332.87 Million | ▼ -33.3% |
| 2017 | 0.84x | CN¥1.22 Billion | CN¥1.46 Billion | CN¥331.67 Million | ▲ +55.1% |
| 2016 | 0.54x | CN¥775.06 Million | CN¥1.43 Billion | CN¥245.06 Million | ▲ +33.7% |
| 2015 | 0.40x | CN¥426.57 Million | CN¥1.06 Billion | CN¥235.57 Million | ▲ +97.7% |
| 2014 | 0.20x | CN¥200.65 Million | CN¥982.25 Million | CN¥200.65 Million | ▼ -68.0% |
| 2013 | 0.64x | CN¥427.20 Million | CN¥668.52 Million | CN¥427.20 Million | ▲ +16.2% |
| 2012 | 0.55x | CN¥286.75 Million | CN¥521.21 Million | CN¥286.75 Million | ▼ -40.7% |
| 2011 | 0.93x | CN¥252.60 Million | CN¥272.32 Million | CN¥252.60 Million | ▼ -22.5% |
| 2010 | 1.20x | CN¥223.48 Million | CN¥186.65 Million | CN¥223.48 Million | ▲ +18.5% |
| 2009 | 1.01x | CN¥135.68 Million | CN¥134.28 Million | CN¥135.68 Million | ▲ +28.0% |
| 2008 | 0.79x | CN¥61.48 Million | CN¥77.89 Million | CN¥61.48 Million | ▲ +203.8% |
| 2007 | 0.26x | CN¥13.71 Million | CN¥52.75 Million | CN¥13.71 Million | ▼ -67.9% |
| 2006 | 0.81x | CN¥9.71 Million | CN¥12.00 Million | CN¥9.71 Million | — |